Detalhe da pesquisa
1.
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.
Clin Infect Dis
; 61 Suppl 5: S514-20, 2015 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553683
2.
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.
Clin Infect Dis
; 61 Suppl 5: S521-30, 2015 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553684
3.
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.
N Engl J Med
; 364(24): 2293-304, 2011 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21675889
4.
Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine.
PLoS One
; 7(2): e31050, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22363544
5.
Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers.
Clin Vaccine Immunol
; 18(9): 1492-6, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21752951